Health Care & Life Sciences » Pharmaceuticals | Hwail Pharmaceutical Co. Ltd.

Hwail Pharmaceutical Co. Ltd.

Hwail Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW366
Market Cap
KRW114.86 B
Shares Outstanding
14.41 M
Public Float
8.8 M

Profile

Address
57 Jeyakgongdan 3-gil
Hwaseong GY 18622
Korea, Republic Of
Employees -
Website http://www.hwail.com
Updated 09/14/2018
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following businesses: Pharmaceutical Raw Material, Cephalosporin Antibiotic, Functional Health Food Ingredient. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others.

Financials

View All
Created with Highcharts 5.0.14Hwail Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.4 2094 2094 1324 1325 4535 4536 3826 3822 6652 6652013201420152016201702k4k6k8k
Created with Highcharts 5.0.14Hwail Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.94 16694 16696 10396 103106 130106 130111 519111 519102 463102 46320132014201520162017025k50k75k100k125k

Joong-Myung Cho
Chairman & Co-Chief Executive Officer
Phil-Joon Park
President, Co-Chief Executive Officer & Director